Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Thymic tumors].

C Le Péchoux1, M Mahé, J-J Bretel

  • 1Département de radiothérapie, institut Gustave-Roussy, 39, rue Camille-Desmoulins, 94000 Villejuif, France. lepechoux@igr.fr

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|September 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung cancer brain metastases management at the dawn of personalized medicine: are we ready to break the barriers?

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Defining the Clinical Target Volume in Postoperative Thymic Epithelial Tumours - A Clinical Practice Guide for UK Clinical Oncologists.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Enhancing radiotherapy with PARP inhibition in soft-tissue sarcomas: a promising synergy requiring specific attention to normal tissues?

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Radiotherapy in the management of lung oligometastases.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Management of oligometastatic/metastatic sarcomas and place of local treatments with focus on modern radiotherapy approaches.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Same author

Intraoperative motive for incomplete resection in primary retroperitoneal sarcoma.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023

Thymomas and thymic carcinomas are rare anterior mediastinum tumors. Complete surgical resection is the primary treatment, with radiotherapy and chemotherapy used for advanced or invasive cases.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Radiation Oncology

Context:

  • Thymomas and thymic carcinomas are rare tumors originating in the anterior mediastinum.
  • These neoplasms are frequently linked to autoimmune conditions, notably myasthenia gravis.

Purpose:

  • To summarize current treatment strategies for thymomas and thymic carcinomas.
  • To discuss the role of surgery, radiotherapy, and chemotherapy in managing these rare tumors.

Summary:

  • Complete surgical resection is the standard treatment for thymomas and thymic carcinomas.
  • Postoperative radiotherapy is utilized for invasive thymoma, though its use in capsular invasion (Stage II) is debated.
  • For unresectable, locally advanced, or metastatic disease, neoadjuvant chemotherapy followed by surgery and radiotherapy has shown promise.

Related Experiment Videos

Impact:

  • This information aids clinicians in optimizing treatment protocols for thymic malignancies.
  • Understanding treatment nuances can improve patient outcomes for these rare cancers.
  • Highlights the evolving role of multimodal therapy in managing advanced thymic tumors.